Robert Venuti
Papers
1
Total Citations
4
H-Index
1
About
Dr. Robert Venuti is a clinical researcher whose work centers on gastrointestinal motility disorders, with a particular focus on gastroparesis and the therapeutic potential of ghrelin receptor agonists. His most cited study, the Phase 2 trial of TZP-102, demonstrated that this ghrelin agonist significantly improved cardinal symptoms of gastroparesis—including nausea, early satiety, bloating, and abdominal pain—and that these improvements correlated strongly with patients’ global ratings of treatment effect. This work helped validate ghrelin agonism as a viable mechanism for addressing the debilitating symptoms of diabetic and idiopathic gastroparesis, a condition with limited pharmacologic options. While his citation count reflects a niche but impactful contribution, Dr. Venuti’s research has informed subsequent clinical development in prokinetic therapies and patient-reported outcome measures. His findings underscore the importance of aligning objective symptom relief with subjective patient experience, a principle increasingly central to trial design in functional gastrointestinal disorders.
Research Focus
Key Achievements
Top Papers
- 1